J.P. Morgan Private Wealth Advisors LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
J.P. Morgan Private Wealth Advisors LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$343,156
-19.2%
11,185
+5.6%
0.00%
-50.0%
Q2 2023$424,542
-52.5%
10,595
-51.7%
0.00%0.0%
Q1 2023$894,474
+45.8%
21,918
+38.0%
0.00%
+100.0%
Q4 2022$613,320
-50.8%
15,885
-32.2%
0.00%
-66.7%
Q3 2022$1,247,000
+7.8%
23,439
+18.1%
0.00%0.0%
Q2 2022$1,157,000
-38.2%
19,844
-19.2%
0.00%
-25.0%
Q1 2022$1,873,000
-21.0%
24,547
-37.7%
0.00%
-20.0%
Q4 2021$2,371,000
+21.6%
39,401
+13.2%
0.01%0.0%
Q3 2021$1,950,000
-7.3%
34,817
+0.4%
0.01%0.0%
Q2 2021$2,104,000
+61.6%
34,668
+86.7%
0.01%
+25.0%
Q1 2021$1,302,000
-36.6%
18,571
-45.9%
0.00%
-42.9%
Q4 2020$2,055,000
+97.8%
34,347
+98.8%
0.01%
+75.0%
Q3 2020$1,039,000
+33.5%
17,275
+16.5%
0.00%0.0%
Q2 2020$778,000
+156.8%
14,832
+64.2%
0.00%
+100.0%
Q1 2020$303,000
-13.7%
9,031
+16.6%
0.00%0.0%
Q4 2019$351,000
+10.4%
7,742
-7.4%
0.00%0.0%
Q3 2019$318,000
+23.7%
8,357
+41.2%
0.00%
+100.0%
Q2 2019$257,000
-3.7%
5,919
-15.6%
0.00%0.0%
Q1 2019$267,000
-17.1%
7,013
-6.2%
0.00%
-50.0%
Q4 2018$322,000
+24.8%
7,480
+42.6%
0.00%
+100.0%
Q3 2018$258,000
+28.4%
5,244
+19.3%
0.00%0.0%
Q4 2017$201,000
-11.5%
4,394
+71.6%
0.00%
-66.7%
Q1 2015$227,0000.0%2,5600.0%0.00%0.0%
Q4 2014$227,000
-8.5%
2,5600.0%0.00%0.0%
Q3 2014$248,000
+5.5%
2,5600.0%0.00%
-25.0%
Q2 2014$235,0002,5600.00%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Gagnon Advisors, LLC 251,140$19,167,0008.83%
GAGNON SECURITIES LLC 610,933$46,626,0007.60%
Tamarack Advisers, LP 205,000$15,646,0007.40%
Spyglass Capital Management LLC 1,871,040$142,798,0004.88%
Lisanti Capital Growth, LLC 302,413$23,080,0002.59%
Rock Springs Capital Management LP 1,000,000$76,320,0001.92%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 208,197$15,890,0001.76%
JABODON PT CO 49,052$3,744,0001.70%
Zweig-DiMenna Associates LLC 166,675$12,721,0001.70%
NEUMEIER POMA INVESTMENT COUNSEL LLC 317,425$24,226,0001.63%
View complete list of PACIRA PHARMACEUTICALS INC shareholders